1. Susan Orr

    0 Comments Leave a Comment

    1-3 of 3
    1. Mentioned In 3 Articles

    2. Notal Vision Engages Wasatch Photonics Bringing AI-Enabled Home-Based Optical Coherence Tomography Closer to Market

      Notal Vision Engages Wasatch Photonics Bringing AI-Enabled Home-Based Optical Coherence Tomography Closer to Market
      ...inging this leading-edge technology to eAMD patients, their caregivers, and the eye care community," said Dr. Susan Orr, Chief Medical Officer at Notal Vision and incoming Chief Executive Officer. “Our collaboration with...
      Read Full Article
    3. Notal Vision Announces FDA Grants Breakthrough Device Designation for Pioneering Patient-Operated Home Optical Coherence Tomography (OCT) System

      Notal Vision Announces FDA Grants Breakthrough Device Designation for Pioneering Patient-Operated Home Optical Coherence Tomography (OCT) System
      ...dard-of-care regularly scheduled examinations and clinical testing by an ophthalmic retinal specialist." Dr. Susan Orr, Chief Medical Officer at Notal Vision and incoming Chief Executive Officer as of January 1, 2019 st...
      Read Full Article
    4. Notal Vision Announces Appointment of Dr. Susan Orr as Chief Executive Officer

      Notal Vision Announces Appointment of Dr. Susan Orr as Chief Executive Officer
      ...f growth and expansion, current Chief Executive Officer, Quinton Oswald, will retire at the end of this year. Susan Orr, OD, Chief Medical Officer and Vice President of Medical Affairs, has been appointed CEO, effective ...
      Read Full Article
    5. 1-3 of 3
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Susan Orr

    Susan Orr

    Susan Orr is the CEO, Chief Medical Officer and Vice President of Medical Affairs at Notal Vision. Previously, Dr. Orr held a range of leadership roles at Alcon, before and after the Novartis acquisition, followed by Janssen (Pharmaceutical Companies of J&J) before joining Notal Vision in 2016. With a back-of-the-eye focus over the past 15 years, Dr. Orr has had both R&D and Commercial responsibilities including Pharmaceutical Alliances (BD&L) where she was key in the acquisition of ESBA1008, now known as brolucizumab. Dr. Orr also held leadership roles in Pipeline Strategy, New Product Strategy, Medical Affairs, and Clinical Development programs. Moving to industry in 1997 following 10 years in private optometric practice in Canada, Dr. Orr completed both her undergraduate (BSc) and graduate degrees (OD) at the University of Waterloo, Ontario.

  3. Quotes

    1. The initiation of our first U.S. based home OCT clinical trial is an important step towards bringing this leading-edge technology to eAMD patients, their caregivers, and the eye care community...Our collaboration with Wasatch Photonics will continue to be instrumental to our organization as the U.S. Food and Drug Administration (FDA) recently granted our Home Optical Coherence Tomography (OCT) System with ‘Breakthrough Device Designation’, a program designed to expedite patient access to novel technologies.
      In Notal Vision Engages Wasatch Photonics Bringing AI-Enabled Home-Based Optical Coherence Tomography Closer to Market